What CPT (Current Procedural Terminology) code should be used for the removal of a lesion suspected to be a skin tag, but with uncertain diagnosis requiring pathology confirmation, in an adult patient?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

CPT Coding for Uncertain Skin Lesion Requiring Pathology

When you are uncertain whether a lesion is a benign skin tag and need pathological confirmation, you must code it as an excision rather than a simple skin tag removal, using CPT codes 11400-11446 (excision of benign lesion) or 11600-11646 (excision of malignant lesion) based on final pathology, with code selection determined by the lesion size plus margins and anatomic location.

Coding Algorithm for Uncertain Lesions

When Pathology is Required

  • Complete excisional biopsy is the appropriate procedure when diagnosis is uncertain, as this allows full histopathological examination of the entire lesion for accurate diagnosis and staging 1, 2.

  • The excision should include a 2mm margin of normal skin and extend through the full thickness of the dermis with a cuff of subcutaneous fat 1, 3.

  • Measure the lesion diameter plus the narrowest margin prior to excision - this combined measurement determines your CPT code selection 4.

CPT Code Selection Process

  • Use excision codes (11400-11446 for benign, 11600-11646 for malignant) rather than destruction or simple removal codes when sending tissue to pathology 4.

  • Code selection is based on:

    • Greatest clinical diameter of lesion PLUS margins (measured before excision) 4
    • Anatomic location (face/ears/eyelids/nose/lips/mucous membranes vs. other sites) 4
    • Final pathology diagnosis (benign vs. malignant) 4
  • Only the definitive, most complex procedure may be billed - if you attempt a simpler removal first then immediately proceed to excision, only code the excision 4.

Critical Documentation Requirements

Your operative note must include specific elements to support accurate coding:

  • Pre-excision measurements: Document the lesion's greatest clinical diameter plus the margin width you plan to excise 4

  • Clinical description: Record appearance, size, exact anatomic location, and your differential diagnosis including why you're uncertain it's a benign skin tag 1

  • Pathology form details: Provide complete clinical history, relevant previous history, anatomic site, and differential diagnosis to the pathologist 3, 1

  • Excision technique: Document that you performed full-thickness excision through the dermis with subcutaneous fat 1

Common Coding Pitfalls to Avoid

  • Never code as simple skin tag removal (11200-11201) when sending to pathology - these codes are for destruction/removal of clearly benign lesions not requiring histological examination 4.

  • Do not use shave biopsy codes if you performed full excision - shave biopsies should be avoided when melanoma or other serious pathology needs exclusion, as they prevent accurate staging 3, 1.

  • Avoid coding before receiving final pathology - the distinction between benign (11400 series) and malignant (11600 series) codes depends on the pathologist's diagnosis 4.

  • Do not bill separately for simple closure - this is included in the excision code 4.

When Uncertainty Exists

If clinical examination cannot definitively confirm a benign skin tag, complete excisional biopsy is medically necessary to exclude melanoma, squamous cell carcinoma, or other malignancies that may occasionally present in pedunculated lesions 5.

Partial sampling techniques (punch biopsy, shave biopsy) should not be used when there is diagnostic uncertainty, as they risk sampling error and prevent accurate pathological staging 3, 1, 2.

References

Guideline

Treatment of Non-Traumatic Skin Lesions

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Diagnosis and Management of Suspected Melanoma on the Sole

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Physician documentation essential for accurate coding and billing of excision of skin lesions.

The Journal of the Oklahoma State Medical Association, 2006

Research

Skin tags imaged by reflectance confocal microscopy, optical coherence tomography and multispectral optoacoustic tomography at the bedside.

Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.